Danaher Corporation
NYSE:DHR · New York Stock Exchange
-$0.38 today
Vol 3.13M · Avg 4.52M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-9.14%
Period High
$241.53
Period Low
$161.91
Latest
$177.17
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Amgen Inc.
NASDAQ:AMGN
$180.68B
Thermo Fisher Scientific Inc.
NYSE:TMO
$172.94B
Gilead Sciences, Inc.
NASDAQ:GILD
$152.44B
Pfizer Inc.
NYSE:PFE
$143.83B
Intuitive Surgical, Inc.
NASDAQ:ISRG
$143.62B
Stryker Corporation
NYSE:SYK
$118.98B
Sanofi
NASDAQ:SNY
$101.46B
Medtronic plc
NYSE:MDT
$101.30B
McKesson Corporation
NYSE:MCK
$87.94B
Boston Scientific Corporation
NYSE:BSX
$67.35B
What is the latest DHR filing?
The latest filing shown is 11-K dated Jun 16, 2026.
How many recent filings does DHR have?
Intrinsic Alpha currently shows 20 recent filings for DHR.
Explore More
Continue the stock analysis
Jump to another research area for this company.